The CMA's investigation into the suspected unfair pricing of phenytoin sodium capsules started in May 2013. Needless to say, it has been...

Well, it's finally here. Yesterday marked the Date of Application of the European Union's new In Vitro Diagnostic Medical Device...

In the latest development in the ‘connected car wars’, IP Bridge (a member of the Avanci pool) has obtained an injunction against Ford in...

Last month, Netflix surprised industry analysts by announcing that for the first time in a decade, the company had lost 200,000...

We have been waiting for the first use by the Government of its powers to 'call in' for review transactions which raise potential...

On Friday, the Guardian newspaper shared comments from Peter Thompson, chief executive of the Human Fertilisation and Embryology...

This analysis was first published on Lexis®PSL on 17 May 2022.  What does the proposal for the EU Data Act mean for the planned revision...

BVMed, the German trade body for MedTech, has been quite vocal on the subject of the new EU Medical Device Regulation (MDR) lately....

On 9 May 2022, the Digital, Culture, Media and Sport (DCMS) Committee published its report  'Influencer Culture: Lights, Camera,...

Here is my off-the-cuff reaction to the UK government's briefing note on a bill announced in this afternoon's Queen's speech: the Genetic...

Across all industries, companies of all sizes are undertaking and/or contemplating digital projects. Sometimes, these projects are small...